MSI’s health financing assessments 2012-2015

What did we learn about UHC financing and contraception? Four ‘Ps’ matter

Make a change

Help empower women worldwide with access to life-changing reproductive health care.

Donate Now

In the report, you will read what we have learned about health financing for contraception in 20 countries, with a focus on purchasing and risk pooling. All countries assessed had public financing approaches in place for contraception. However, within these, we saw that financing contraception was often focused on the commodity and not the service. We saw that payments to providers tended to be either too low powered or too high powered - both approaches showed the signs of provider bias and eroded choice. We observed that maternal health and contraception financing reforms have not stayed hand in hand. And we learned that, in general, midlevel private providers are not accessing public financing flows despite the role they can play to extend Universal Health Coverage and reduce unmet need for contraception.

Download the report here.

Our Global Impact Last Year

32million

women using a MSI
method of contraception

13million

unintended pregnancies
prevented

6.5million

unsafe abortions prevented

34,600

pregnancy-related deaths prevented